TCL Archive Rapid Non-Invasive Imaging Of Biochemical Composition In Breast Tumor Margins April 24, 2009
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983